Clinical systems · Multi-specialty ambulatory EHR
PrognoCIS
PrognoCIS is a cloud multi-specialty ambulatory EHR and practice management suite from Bizmatics (Harris Computer). It is not an inpatient hospital EHR.
Strong fit
- Multi-specialty ambulatory practices evaluating a customizable cloud EHR with billing and patient engagement
- Groups comfortable buying a Harris Computer / Bizmatics ambulatory product with established specialty templates
- Buyers comparing mid-market ambulatory EHRs rather than Epic hospital builds
Weak fit
- Health systems that need inpatient Epic or Oracle Health as the core chart
- Practices that require a physician-owned specialty vendor with a strong ENT-only brand story
- Buyers that refuse products owned by larger healthcare software conglomerates
Bottom line
PrognoCIS earns a Conditional on our ambulatory EHR board. The cloud EHR and practice management suite from Bizmatics (a Harris Computer company) targets multi-specialty ambulatory groups with customizable templates, billing, and portal tools. Third-party markers for Bizmatics cluster near roughly $31M revenue with several hundred employees, inside mid-market range under the hard cap even as a Harris subsidiary. Outcomes look best when the practice accepts conglomerate ownership and focuses on template fit and RCM handoffs. Product depth is comparable to CharmHealth and Azalea for community ambulatory needs; it trails RXNT on independent mid-market brand momentum and trails WRS Health for physician-led specialty narrative. Score ties Azalea and sits just above CharmHealth and DrChrono.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
PrognoCIS is a cloud ambulatory EHR and practice management suite from Bizmatics, a Harris Computer company, with leadership associated with CEO Vinay Deshpande. The product targets multi-specialty clinics that need charting, scheduling, billing, and patient engagement in one system.
It is mid-market ambulatory clinical software, not an inpatient hospital EHR. Compare RXNT and CharmHealth for independent cloud ambulatory peers, WRS Health for specialty-first physician branding, and Azalea for community and rural ambulatory contexts.
Score reflects workable multi-specialty coverage with softer marks on ownership concentration and price transparency.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Canvas Medical | 7.5 | 7.2 |
| RXNT | 7.5 | 7.3 |
| Elation Health | 7.4 | 7.0 |
| WRS Health | 7.2 | 7.0 |
| Azalea Health | 6.9 | 6.8 |
| PrognoCIS | 6.9 | 6.7 |
| CharmHealth | 6.8 | 6.7 |
| DrChrono | 6.7 | 6.6 |
Pricing
| Item | Detail |
|---|---|
| Model | Cloud EHR / PM subscription often quoted per provider with optional RCM services. |
| What usually drives cost | Provider seats, specialty modules, billing services, and data migration. |
| What to ask in diligence | Per-provider monthly all-in cost including clearinghouse and conversion. |
| Published pricing | Third-party directories often cite roughly $280/provider/month starting points; confirm current PrognoCIS quotes directly. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get PrognoCIS to function | |
| Multi-specialty template map | Customization without a map stalls. |
| Billing ownership assigned | EHR+PM fails without RCM owner. |
| Data conversion vendor or internal lead | Migrations need a name. |
| Patient engagement / portal plan | Portal is part of the suite. |
| Conglomerate procurement path accepted | Harris ownership can lengthen contracting. |
| What will maximize your value | |
| Pilot one specialty pod first | Big-bang multi-specialty increases risk. |
| Freeze customizations 2 weeks before train | Stops thrash. |
| Track denial rates after go-live | Billing truth shows fast. |
| Deal-breakers | |
| Epic inpatient mandate | |
| Refuse Harris-owned products | |
| No conversion window | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Contract and discovery | 2-6 weeks |
| 2 | Build | 6-10 weeks |
| 3 | Go-live hypercare | 2-4 weeks |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.